Genome-wide association study suggests genetic candidate loci of insulin dysregulation in Finnhorses.

This research article explores the possible genetic loci (specific locations of genes on a chromosome) associated with insulin dysregulation, a key characteristic of Equine Metabolic Syndrome (EMS), in Finnhorses.

Research Background

• The article focuses on understanding the genetic factors contributing to Equine Metabolic Syndrome (EMS), a common issue in horses that is often marked by insulin dysregulation, a higher risk of laminitis, and frequently obesity.
• The genesis of EMS is multifactorial, i.e., a mix of genetic and environmental causes, like diet and physical activity. While we have a decent understanding of the environmental contributors and they can be modulated to manage the disease, the genetic elements remain poorly understood and can’t be directly controlled.

Objective of the Study

• The main purpose of this study was to identify potential genetic loci that might influence insulin dysregulation or EMS in Finnhorses, a breed of horses.

Methodology

• The researchers conducted a single-breed genome-wide association study (GWAS), a common method used to examine variants of genes in different individuals to identify if any variant is associated with a trait.
• They used a case-control study where horses with insulin dysregulation were considered cases, and age-appropriate horses without insulin dysregulation were used as controls.
• Horses’ insulin dysregulation status was determined using an oral sugar test.
• DNA samples from 71 Finnhorses were collected and genotyped for 65,157 single-nucleotide polymorphisms (SNPs), variations at a single position in a DNA sequence, using the Illumina Equine SNP70 BeadChip.

Results

• The genomic data were analysed, and it was found that two SNPs exceeded the suggestive threshold, SNP BIEC2_383954 in chromosome 17 and SNP BIEC2_312374 in chromosome 15. Outlier tests also detected these two SNPs.
• The researchers identified two potential candidate genes associated with insulin dysregulation located close to SNP BIEC2_383954. These genes – Arginine and Glutamate rich 1 (ARGLU1) and Ephrin-B2 (EFNB2) – are known to have roles in carbohydrate metabolism.

Conclusion

• This study, hence, indicates potential genetic loci that may be contributing to insulin dysregulation in Finnhorses, thereby enhancing our understanding of the genetic factors influencing EMS in horses.